ArticleFood and environmental virology2012
Quantitative detection and characterization of human adenoviruses in the Buffalo River in the Eastern Cape Province of South Africa.
Article in Food and environmental virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Occurrence of Human Enteric Viruses in Water Sources and Shellfish: A Focus on Africa.Food and environmental virology · 2021Review
- Viral indicators for tracking domestic wastewater contamination in the aquatic environment.Water research · 2020Review
- Quantitative PCR Detection and Characterisation of Human Adenovirus, Rotavirus and Hepatitis A Virus in Discharged Effluents of Two Wastewater Treatment Facilities in the Eastern Cape, South Africa.Food and environmental virology · 2016Article
- Presence of Human and Animal Viruses in Surface Waters in Vojvodina Province of Serbia.Food and environmental virology · 2015Article
- Assessment of the risks for human health of adenoviruses, hepatitis A virus, rotaviruses and enteroviruses in the Buffalo River and three source water dams in the Eastern Cape.Food and environmental virology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Buffalo River is an important water resource in the Eastern Cape Province of South Africa. Over a 1-year period (August 2010-July 2011), we assessed the prevalence of human adenoviruses (HAdVs) at a total of 6 sites on the river and three dams along its course. HAdVs were detected by real-time quantitative PCR in about 35 % of the samples with concentrations ranging from 1.2 × 10(1) genome copies (GC)/l to 4.71 × 10(3) GC/l. HAdVs were detected at 5 of the 6 sampling sites with the detection rate ranging from 8.3 % at Rooikrantz Dam to 92 % at Parkside. The HAdV concentrations across the sampling sites were as follows: Parkside (3.25 × 10(2)-4.71 × 10(3) GC/); King William's Town (1.02 × 10(2)-4.56 × 10(3) GC/l); and Eluxolzweni (1.17 × 10(2)-3.97 × 10(2) GC/l). Significantly (P < 0.05) higher concentrations were detected at the non-dam sites compared to the dam sites. A very low mean concentration of 1.86 × 10(1) HAdV GC/l was observed at Bridle Drift Dam. While HAdVs were detected only once at Rooikrantz Dam (1.74 × 10(1) GC/l), no HAdV was detected at Maden Dam. Epidemiologically important serotypes, Ad40/41, constituted 83.3 %, while Ad21 made up 16.7 % of the all HAdVs detected and were characterized by qualitative PCR. The Buffalo River presents a public health risk heightened by the presence of Ad 40/41 and Ad21. Our results make imperative the need for assessing water sources for viral contamination in the interest of public health. This work is a significant contribution to the molecular epidemiology of adenoviruses and to the best of our knowledge this is the first report on detection of enteric virus from surface waters in the Eastern Cape.
Indexed as
Identifiers
23412891What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.